| Average initial daily dose | 2013 | 2018 |
|---|---|---|
| - | - | - |
| - | - | - |
| - | - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
Release date
October 2019
Region
Canada
Survey time period
2013 and 2018
Supplementary notes
* MMEs: Morphine milligram equivalents
Includes data from Ontario, Saskatchewan and British Columbia. Manitoba is excluded from trends because data prior to March 2015 is unavailable.
Citation formats








